Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Johnson and Johnson
Boehringer Ingelheim
Moodys
Merck

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CARBAMAZEPINE

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for carbamazepine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000191 ↗ Carbamazepine Treatment for Cocaine Dependence - 5 Completed National Institute on Drug Abuse (NIDA) Phase 2 1991-01-01 The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.
NCT00000191 ↗ Carbamazepine Treatment for Cocaine Dependence - 5 Completed University of Pennsylvania Phase 2 1991-01-01 The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.
NCT00000217 ↗ Pharmacotherapy and Intensive Treatment of Drug Abuse - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1990-09-01 The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
NCT00000217 ↗ Pharmacotherapy and Intensive Treatment of Drug Abuse - 1 Completed US Department of Veterans Affairs Phase 2 1990-09-01 The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
NCT00000217 ↗ Pharmacotherapy and Intensive Treatment of Drug Abuse - 1 Completed VA Office of Research and Development Phase 2 1990-09-01 The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
NCT00000217 ↗ Pharmacotherapy and Intensive Treatment of Drug Abuse - 1 Completed University of Kansas Phase 2 1990-09-01 The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for carbamazepine

Condition Name

Condition Name for carbamazepine
Intervention Trials
Epilepsy 34
Bipolar Disorder 17
Seizures 8
Bronchial Asthma 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for carbamazepine
Intervention Trials
Epilepsy 45
Bipolar Disorder 22
Seizures 17
Disease 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for carbamazepine

Trials by Country

Trials by Country for carbamazepine
Location Trials
United States 160
Italy 24
Germany 18
Australia 16
United Kingdom 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for carbamazepine
Location Trials
Maryland 13
New York 12
North Carolina 10
Texas 9
California 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for carbamazepine

Clinical Trial Phase

Clinical Trial Phase for carbamazepine
Clinical Trial Phase Trials
Phase 4 53
Phase 3 35
Phase 2/Phase 3 5
[disabled in preview] 54
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for carbamazepine
Clinical Trial Phase Trials
Completed 111
Unknown status 17
Terminated 13
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for carbamazepine

Sponsor Name

Sponsor Name for carbamazepine
Sponsor Trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 10
GlaxoSmithKline 7
UCB Pharma 7
[disabled in preview] 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for carbamazepine
Sponsor Trials
Other 169
Industry 85
NIH 21
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Express Scripts
Boehringer Ingelheim
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.